D475-2544 Screening compound: 3-{1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-1-(morpholin-4-yl)propan-1-one

D475-2544 Screening compound: 3-{1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-1-(morpholin-4-yl)propan-1-one
D475-2544 Screening compound: 3-{1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-1-(morpholin-4-yl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound D475-2544
3-{1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-1-(morpholin-4-yl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D475-2544

Molecular Formula

C20H21FN4O3S (C20 H21 FN4 O3 S)

Compound Name

3-{1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-1-(morpholin-4-yl)propan-1-one

IUPAC name

3-{1-[4-(4-fluorophenyl)-13-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-1-(morpholin-4-yl)propan-1-one

SMILES

Cc(c(CCC(N1CCOCC1)=O)c1O)nn1-c1nc(-c(cc2)ccc2F)cs1

InChI

InChI=1S/C20H21FN4O3S/c1-13-16(6-7-18(26)24-8-10-28-11-9-24)19(27)25(23-13)20-22-17(12-29-20)14-2-4-15(21)5-3-14/h2-5,12,27H,6-11H2,1H3

InChI Key

NDLBTGUUWVOFAB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27588652

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

416.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.552

Distribution Coefficient, logD

0.565

Water Solubility, LogSw

-2.49

Polar Surface Area

63.666

Acid Dissociation Constant (pKa)

5.42

Base Dissociation Constant (pKb)

4.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

D475-2544 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D475-2544 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D475-2544?
Check Price and Availability of D475-2544, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D475-2544 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D475-2544
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D475-2544
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D475-2544 available by request